Seeing Is Believing
Currently out of the existing stock ratings of Mohit Bansal, 133 are a BUY (62.44%), 76 are a HOLD (35.68%), 4 are a SELL (1.88%).
Analyst Mohit Bansal, currently employed at WELLS FARGO, carries an average stock price target met ratio of 67.06% that have a potential upside of 26.38% achieved within 190 days.
Mohit Bansal’s has documented 411 price targets and ratings displayed on 32 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MRK, Merck mpany at 01-Nov-2024.
Analyst best performing recommendations are on KRTX (KARUNA THERAPEUTICS).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 11/18/2019. The price target of $115 was fulfilled within 1 day with a profit of $19 (19.79%) receiving and performance score of 197.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$53
$8.13 (18.12%)
$51
7 days ago
(01-Nov-2024)
2/6 (33.33%)
$8.13 (18.12%)
366
Buy
$56
$11.13 (24.80%)
$37
1 months 12 days ago
(27-Sep-2024)
8/12 (66.67%)
$10.39 (22.78%)
250
Hold
$46
$1.13 (2.52%)
$30
4 months 26 days ago
(13-Jun-2024)
4/4 (100%)
$-0.77 (-1.65%)
169
Hold
$53
$8.13 (18.12%)
$33
5 months 4 days ago
(04-Jun-2024)
7/8 (87.5%)
$5.65 (11.93%)
165
Buy
$42
$-2.87 (-6.40%)
$67
1 years 4 months 12 days ago
(27-Jun-2023)
6/12 (50%)
$13.87 (49.31%)
234
Which stock is Mohit Bansal is most bullish on?
Which stock is Mohit Bansal is most reserved on?
What Year was the first public recommendation made by Mohit Bansal?